(S (NP (NP (NNP Melanoma)) (, ,) (NP (NP (CD one)) (PP (IN of) (NP (NP (ADJP (JJS most) (JJ dangerous)) (NNS types)) (PP (IN of) (NP (NN skin) (NN cancer)))))) (, ,)) (VP (NNS re-sults) (PP (IN in) (NP (DT a) (ADJP (RB very) (JJ high)) (NN mortality) (NN rate)))) (. .))
(S (NP (JJ Early) (NN detection) (CC and) (NN resection)) (VP (VBP are) (NP (NP (CD two) (JJ key) (NNS points)) (PP (IN for) (NP (DT a) (JJ successful) (NN cure))))) (. .))
(S (NP (JJ Recent) (NN research)) (VP (VBZ has) (VP (VBN used) (NP (JJ artificial) (NN intelligence)) (S (VP (VP (TO to) (VP (VB classify) (NP (NN melanoma) (CC and) (NN nevus)))) (CC and) (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN assessment)) (PP (IN of) (NP (DT these) (NNS algorithms)))) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NNS dermatologists))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (DT an) (NN imbalance)) (PP (IN of) (NP (NN sensitivity) (CC and) (NN specificity) (NNS measures)))) (VP (VBD affected) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (VBG existing) (NNS models))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ proposes) (NP (NP (DT a) (NN method)) (VP (VBG using) (NP (JJ deep) (JJ convolutional) (JJ neural) (NNS networks))) (VP (VBG aiming) (S (VP (TO to) (VP (VB detect) (NP (NN melanoma)) (PP (IN as) (NP (DT a) (JJ binary) (NN classification) (NN problem))))))))) (. .))
(S (NP (PRP It)) (VP (VBZ involves) (NP (NP (CD 3) (NN key) (NNS features)) (, ,) (ADVP (RB namely)) (NP (NP (JJ customized) (NN batch) (NN logic)) (, ,) (NP (JJ customized) (NN loss) (NN function)) (CC and) (NP (VBD reformed) (ADJP (RB fully) (VBN connected)) (NNS layers))))) (. .))
(S (S (NP (DT The) (NN training) (NN dataset)) (VP (VBZ is) (VP (VBN kept) (PP (RB up) (PP (TO to) (NP (NN date)))) (PP (VBG including) (NP (NP (CD 17,302) (NNS images)) (PP (IN of) (NP (NN melanoma) (CC and) (NN nevus)))))))) (: ;) (S (NP (DT this)) (VP (VBZ is) (NP (DT the) (JJS largest) (NN dataset)) (PP (IN by) (ADVP (RB far))))) (. .))
(S (NP (DT The) (NN model) (NN performance)) (VP (VBZ is) (VP (VBN compared) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NP (CD 157) (NNS dermatologists)) (PP (IN from) (NP (NP (CD 12) (NN university) (NNS hospitals)) (PP (IN in) (NP (NNP Germany))))))))) (PP (VBN based) (PP (IN on) (NP (NNP MClass-D) (NN dataset)))))) (. .))
(S (NP (DT The) (NN model)) (VP (VP (VBD outperformed) (NP (DT all) (CD 157) (NNS dermatologists))) (CC and) (VP (VBD achieved) (NP (JJ state-of-the-art) (NN performance)) (PP (IN with) (NP (NP (NNP AUC)) (PP (IN at) (NP (CD 94.4) (NN %))))) (PP (IN with) (NP (NP (NP (NN sensitivity)) (PP (IN of) (NP (CD 85.0) (NN %)))) (CC and) (NP (NP (NN specificity)) (PP (IN of) (NP (CD 95.0) (NN %)))))) (S (VP (VBG using) (NP (NP (DT a) (NN prediction) (NN threshold)) (PP (IN of) (NP (CD 0.5)))) (PP (IN on) (NP (NP (DT the) (NNP MClass-D) (NN dataset)) (PP (IN of) (NP (CD 100) (NN dermoscopic) (NNS images))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (NP (DT a) (NN threshold)) (PP (IN of) (NP (CD 0.40858)))) (VP (VP (VBD showed) (NP (NP (DT the) (ADJP (RBS most) (JJ balanced)) (NN measure)) (PP (VBN compared) (PP (TO to) (NP (JJ other) (NNS researches)))))) (, ,) (CC and) (VP (VBZ is) (ADVP (RB promisingly)) (NP (NN application) (PP (TO to) (NP (JJ medical) (NN diagnosis)))) (, ,) (PP (IN with) (NP (NP (NP (NN sensitivity)) (PP (IN of) (NP (CD 90.0) (NN %)))) (CC and) (NP (NP (NN specificity)) (PP (IN of) (NP (CD 93.8) (NN %)))))))) (. .))
